Kazuyasu Maruyama

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet

Tatsuya Nagasawa, Yoichi Inada, Shigeru Nakano et al. · European Journal of Pharmacology · 2006 · 228 citations

Metabolic Syndrome, Medicine, Liver Physiology +9

Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes

Shigeru Nakano, Yoichi Inada, Hiroaki Masuzaki et al. · American Journal of Physiology-Endocrinology and Metabolism · 2006 · 41 citations

3T3-l1 Adipocytes, Murine Adipose Tissue, Adipokines +20

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor‐β1 in a cultured stellate cell line

Shigeru Nakano, Tatsuya Nagasawa, Tomoyuki Ijiro et al. · Hepatology Research · 2008 · 38 citations

Protective Effects of Ranolazine, a Novel Anti-ischemic Drug, on the Hydrogen Peroxide-Induced Derangements in Isolated, Perfused Rat Heart: Comparison With Dichloroacetate

Hisao Matsumura, Akiyoshi Hara, Hiroko Hashizume et al. · The Japanese Journal of Pharmacology · 1998 · 37 citations · Full text

Ranolazine Attenuates Palmitoyl-<scp>l</scp>-carnitine-induced Mechanical and Metabolic Derangement in the Isolated, Perfused Rat Heart

Kazuyasu Maruyama, Akiyoshi Hara, Hiroko Hashizume et al. · Journal of Pharmacy and Pharmacology · 2000 · 30 citations · Full text

Heart Failure, Induced Mechanical Dysfunction, Cardiovascular Pharmacology +16